Purpose This paper aims to test whether supplier concentration (SC), dependence on a few upstream vendors, pushes firms to integrate backwards through M acquisitiveness is measured by the annual count and total value (log) of supplier-targeted deals. Fixed-effects regressions, event-study cumulative abnormal returns, long-run buy-and-hold abnormal returns (BHARs), post-deal changes in dependence and structural equation modeling mediation analyses (cash, relationship-specific R&D) constitute the empirical toolkit. Findings A one-standard-deviation increase in SC raises the likelihood of a vertical acquisition by 11% and increases deal value by 44%. Announcement returns of 1.9–2.7% and BHARs up to 17% indicate sustained value creation. Three years after completion, the major supplier’s purchase share falls by 8% and ROA improves by roughly 9%. The effect is channeled through the acquirer’s cash-richness, while the acquirer’s more relationship-specific investment dampens the impact. Originality/value The study introduces SC as a first-order determinant of takeover activity, offering fresh support for transaction-cost and resource-dependence theories. It shows that arm’s-length vertical acquisitions effectively hedge against upstream shocks, informing managers’ boundary decisions and policymakers’ efforts to bolster supply-chain resilience.
Rehman et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: